We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Lipoxen | LSE:LPX | London | Ordinary Share | GB00B08NWV55 | ORD 0.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.875 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2019 to Dec 2024
TIDMLPX
RNS Number : 8984Z
Lipoxen PLC
21 January 2011
Lipoxen plc
("Lipoxen" or the "Company")
Director dealings
The Company was informed on 20 January 2011 that FDS Pharma Ass and Related Parties disposed of 925,000 ordinary shares of 0.5p each ("Ordinary Shares") over 16 separate trades at an average price of 11.23 pence between 16 November and 13 December 2010.
Following these disposals FDS Pharma Ass and Related Parties have an interest in Lipoxen of 41,440,059 Ordinary Shares representing 23.38 per cent of the issued Ordinary Share capital in the Company.
Enquires:
Hot Features
Premium
Lipoxen plc +44 (0)20 7389 5015
M. Scott Maguire, Chief Executive
Officer
Singer Capital Markets (nominated
adviser) +44 (0)20 3205 7500
Jeff Keating / Claes Spang
Walbrook PR Ltd +44 (0)20 7933 8780
Bob Huxford (Media Enquiries) Mob: 07747 653 908
bob.huxford@walbrookpr.com
Paul Cornelius (Investor Enquiries) Mob: 07866 384 707
paul.cornelius@walbrookir.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSMMGZMFMNGMZM
1 Year Lipoxen Chart |
1 Month Lipoxen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
